HeartFlow is committed to supporting ongoing clinical research both through internal research projects and external collaborations.
HeartFlow is proud to sponsor the multi-center, international PRECISE trial. PRECISE will evaluate whether a precision evaluation strategy with CCTA and selective FFRCT can improve outcomes while safely deferring further testing and reducing costs overall as compared to usual care in stable chest pain patients. The precision evaluation arm combines contemporary risk stratification using the PROMISE Risk Tool with functional and anatomic non-invasive evaluation. For further information, please reach out to [email protected].
HeartFlow supports investigator-initiated studies and research projects to further the goal of advancing medical and scientific knowledge. HeartFlow provides funding for certain research that meets this standard and is consistent with applicable laws and HeartFlow’s Ethics and Compliance Program. As such, HeartFlow has established detailed processes to accept and review proposals.
If you are interested in applying, please complete the form below.
HeartFlow is eager to work with clinical research sites and investigators to advance our clinical programs. If you are a researcher interested in HeartFlow’s ongoing or upcoming clinical trials, please reach out to [email protected]. Your information will go into our investigator database as a resource for future study site selection.
If you have additional questions on the HeartFlow Clinical Research,
please contact us at